Coronary Heart Disease
Conditions
Interventions
Standard treatment group:Standard dosage: Atorvastatin (20mg)
Intensive treatment group:Intensive dosage: Atorvastatin (20mg)
Sponsors
Wuhan No. 1 Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 80; 2. Upon admission, complete laboratory tests such as blood routine, liver and kidney function, glucose, electrolytes, and blood lipids; 3. Confirmed patients with coronary heart disease; 4. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. There are malignant tumors, immune system diseases, severe infections, and serious liver and kidney function abnormalities; 2. Contrast agent allergy, etc; 3. There are other diseases that have an impact on autonomic nerve function; 4. There are life-threatening diseases other than coronary heart disease; 5. Unable to cooperate with this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Autonomic neurotransmitters: norepinephrine;Autonomic neurotransmitters: acetylcholine;Blood lipid index: Low-density lipoprotein;Immune inflammatory factors: Interleukin-6;Immune inflammatory factor: Tumor necrosis factor alpha; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability;Echocardiography data;Adiponectin; | — |
Countries
China
Contacts
Public ContactLiqun He
Wuhan No. 1 Hospital
Outcome results
None listed